Thermo Fisher Scientific Inc (TMO)

Mexico
Currency in MXN
11,937.27
-457.73(-3.69%)
Closed

TMO Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa32,21839,21144,91542,85742,879
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+26.14%+21.71%+14.55%-4.58%+0.05%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa16,21419,57325,94425,74424,771
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa16,00419,63818,97117,11318,108
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+41.28%+22.71%-3.4%-9.79%+5.81%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa49.67%50.08%42.24%39.93%42.23%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa8,1379,26610,4119,71910,353
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+13.93%+13.87%+12.36%-6.65%+6.52%
aa.aaaa.aaaa.aaaa.aaaa.aa1,1811,4061,4711,3371,390
aa.aaaa.aaaa.aaaa.aaaa.aa6,9407,8578,9408,3817,011
aa.aaaa.aaaa.aaaa.aaaa.aa163-1-
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,86710,3728,5607,3947,755
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+87.94%+31.84%-17.47%-13.62%+4.88%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa24.42%26.45%19.06%17.25%18.09%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-488-493-454-496-312
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-7.96%-1.02%+7.91%-9.25%+37.1%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-553-536-726-1,375-1,390
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa65432728791,078
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa2-3-105-83-42
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,3819,8768,0016,8157,401
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa--14--
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-32-1,033-123-297-411
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,2278,8377,6636,2396,995
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+77.48%+22.28%-13.29%-18.58%+12.12%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa22.43%22.54%17.06%14.56%16.31%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa8501,109703284657
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa6,3777,7286,9605,9556,338
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-2-3-1040-3
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa6,3757,7256,9505,9956,335
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+72.48%+21.18%-10.03%-13.74%+5.67%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa19.79%19.7%15.47%13.99%14.77%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa6,3757,7256,9505,9956,335
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa16.119.6117.7315.5316.58
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+74.23%+21.79%-9.57%-12.4%+6.78%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa15.9619.4617.6315.4516.53
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+74.05%+21.93%-9.4%-12.37%+6.99%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa396394392386382
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa399397394388383
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa0.881.041.21.41.56
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+15.79%+18.18%+15.38%+16.67%+11.43%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa10,19212,96411,94110,80010,856
EBITDA Growth
aa.aa